News Maxion Therapeutics gets $16m Series A Financing LifeArc Ventures leads $16m Series A of Maxion Therapeutics for antibody development overhaul.
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face
